Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A2ZO
|
|||
| Drug Name |
Phenoxypiperidine derivative 2
|
|||
| Synonyms |
PMID29334795-Compound-37
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
RICHTER GEDEON NYRT
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H30N2O2
|
|||
| Canonical SMILES |
C1CCN(CC1)CCCOC2=CC=C(C=C2)OC3CCNCC3
|
|||
| InChI |
1S/C19H30N2O2/c1-2-13-21(14-3-1)15-4-16-22-17-5-7-18(8-6-17)23-19-9-11-20-12-10-19/h5-8,19-20H,1-4,9-16H2
|
|||
| InChIKey |
IRTTXYWMHFLYFK-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H3 receptor (H3R) | Target Info | . | [1] |
| Target's Patent Info | Histamine H3 receptor (H3R) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Histamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Monoamine Transport | |||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017).Expert Opin Ther Pat. 2018 Mar;28(3):175-196. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.